BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 22, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 27, 2008

View Archived Issues

FTY-720 associated with viral clearance in models of infection

Read More

TRPM8 antagonism may attenuate hypersensitivity to cold

Read More

NP-12 reduces tau and beta-amyloid pathology in mice

Read More

Recent patents report novel treatment options for endocrine disorders

Read More

Novel Rac1/Rac1b inhibitors prevent Abeta production, display improved metabolic stability

Read More

Animal model of siRNA therapy for HIV infection created

Read More

FG-4497 shows promise in rat kidney transplant model

Read More

EP-1013 enhances effects of costimulation blockade for islet transplantation

Read More

Pfizer unveils potent and selective c-Met inhibitor PF-4254644

Read More

New analgesic agents disclosed in recent patent literature

Read More

Recent Roche patent describes new treatments for depression, anxiety

Read More

Otsuka acquires Interpharma Praha from Interpharma West

Read More

AVEO initiates phase Ib combination trial of AV-951 and FOLFOX-6

Read More

Avexa and Shire renegotiate apricitabine license agreement

Read More

Biofrontera and DSE form license agreement for U.S. Relieva distribution

Read More

Galapagos acquires Sareum Holdings' structure-based drug discovery services

Read More

Genzyme and Medicines for Malaria Venture collaborate with Advinus

Read More

Novosom acquires exclusive license for Isis' CD40-targeted antisense inhibitors

Read More

Phase II IMC-A12 and IMC-1121B trial enrolls advanced prostate cancer patients

Read More

Zostavax approved in Canada for the prevention of shingles

Read More

Ark commences patient enrollment in phase III Vitor pilot study in cachexia

Read More

Curis doses first patient in phase I CUDC-101 trial

Read More

FDA fast tracks droxidopa for symptomatic neurogenic orthostatic hypotension

Read More

FDA grants Glivec priority review for gastrointestinal stromal tumors

Read More

FDA issues complete response letter for paliperidone palmitate for schizophrenia

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 22, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing